Focus
Semaglutide
FDA Issues Alert About Overdosing on Weight-Loss Drug After Some Take 5 to 20 Times the Intended Dose
Semaglutide is the active ingredient in popular injectable weight-loss drugs.
FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
The FDA is also investigating reported side effects of aspiration.
Semaglutide Poisoning Reports Jump 1,500 Percent as People Accidentally Overdose
Some people have taken 10 times the recommended dose or even the entire month’s dose due to confusion about the directions.
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found ‘concerning levels of unknown impurities.’
Obesity Drug Wegovy Shows Significant Heart Disease Benefits, but Experts Caution Off-Label Use
A new class of weight-loss drug shows it can significantly reduce heart disease-related death in people without diabetes.
FDA Urges Online Vendors to Stop Sale of Unapproved Weight Loss Drugs
The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs due to public health concerns.
Popular Weight Loss Drugs Taken by Millions Hold Highest Safety Warnings
Ozempic and Wegovy may help people lose weight but are associated with a long list of very serious side effects.
